Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare's Board of Directors, at a meeting held on October 6, 2025, approved multiple key managerial changes effective the same day. Three new directors were appointed: Mr. Rajendra Prasad as Non-Executive Non-Independent Director (56, 20+ years in business and administration), Mr. Umesh Kumar as Additional Executive Director (36, 11+ years in accounts and finance), and Ms. Parul Agarwal as Non-Executive Independent Director (39, 12+ years in finance, subject to shareholder approval). Mrs. Neha Srivastava was appointed as Company Secretary and Compliance Officer. At the same time, Mr. Ramanlal Trivedi resigned as Wholetime Director and Chief Financial Officer citing personal pre-occupation with other work. The board meeting ran from 6:00 PM to 6:30 PM.
The simultaneous appointment of four new KMPs and the exit of the CFO signal a significant management reshuffle, which may create short-term governance uncertainty for shareholders. The company has not yet appointed a replacement CFO, which investors should monitor.